| Effect of garlic extract on markers of lipid metabolism and inflammation in coronary artery disease (CAD) patients: A systematic review and meta‐analysis SK Gadidala, E Johny, C Thomas, M Nadella, K Undela, R Adela Phytotherapy Research 37 (6), 2242-2254, 2023 | 7 | 2023 |
| Effect of garlic on the components of metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials S Varade, M Nadella, A Hirake, S bhausaheb Mungase, A Ali, R Adela Journal of Ethnopharmacology 318, 116960, 2024 | 5 | 2024 |
| Efficacy and safety of saroglitazar in patients with cardiometabolic diseases: a systematic review and meta-analysis of randomized controlled trials DR Durga, N Mounika, P Mudimala, R Adela Clinical Drug Investigation 42 (12), 1049-1064, 2022 | 5 | 2022 |
| Effect of obeticholic acid in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) patients: a systematic review and meta-analysis TS Aishwarya, N Mounika, G Vishwakarma, R Adela RPS Pharmacy and Pharmacology Reports 1 (1), rqac001, 2022 | 5 | 2022 |
| Inflammatory protein signatures as predictive disease-specific markers for non-alcoholic steatohepatitis (NASH) N Mounika, SB Mungase, S Verma, S Kaur, UJ Deka, TS Ghosh, R Adela Inflammation, 1-17, 2024 | 1 | 2024 |
| Platelet-derived sTLT-1 is associated with platelet-mediated inflammation in coronary artery disease patients A Ali, N Mounika, B Nath, E Johny, I Kuladhipati, R Das, M Hussain, ... Cytokine 178, 156581, 2024 | | 2024 |
| Assessment and prediction of cardiovascular risk and associated factors among tribal population of Assam and Mizoram, Northeast India: A cross-sectional study N Mounika, A Ali, N Yasmin, J Saikia, R Bordoloi, S Jangilli, ... Clinical Epidemiology and Global Health 25, 101464, 2024 | | 2024 |
| Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH) N Mounika, A Yadav, P Kamboj, SK Banerjee, UJ Deka, S Kaur, R Adela Plos one 18 (12), e0295839, 2023 | | 2023 |
| Response to Comment on:“Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” DR Durga, N Mounika, P Mudimala, R Adela Clinical Drug Investigation 43 (2), 149-150, 2023 | | 2023 |
| Effect of obeticholic acid in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) patients: A systematic review and meta-analysis N Mounika PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 323-323, 2022 | | 2022 |
